Gift 5 articles to anyone you choose each month when you subscribe. Times are good at Eli Lilly. Wall Street’s insatiable appetite for weight-loss drug stocks looks set to turn the company into ...

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price target of $1,150.00. Alec Stranahan ...

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different compared to many recent ...

The most recent trading session ended with Eli Lilly (LLY) standing at $909.32, reflecting a -1.65% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.4%.

CINCINNATI — Former Bengals cornerback Eli Apple is back in the NFL. The veteran is signing with the Chargers after working out for the team on Monday. Apple will start out on the practice squad ...

With injuries assaulting the cornerback room, the Los Angeles Chargers signed veteran Eli Apple on the Monday after the team’s win over the Denver Broncos. According to NFL Network’s Tom ...

The Food and Drug Administration signed off on a new eczema drug from Eli Lilly. Is Eli Lilly stock a buy right now? Eli Lilly, Novo Nordisk, PPH, HRTS and THNR are part of the Zacks top Analyst Blog.

Two-time Super Bowl MVP Eli Manning, former Defensive Players of the Year Luke Kuechly and Terrell Suggs, and postseason kicking hero Adam Vinatieri are among the first-time nominees for the Pro ...

That seemed to be the case for former Alabama quarterback Eli Holstein, who entered the transfer portal after last season after one year in Tuscaloosa. Holstein announced his transfer from Alabama ...

Eli Lilly's long-term growth prospects have been secured by the improved supply in H2'24 and the incoming capacity additions from H1'25 onwards. This is on top of the introduction of its D2C ...

Sept 24 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment ...